1h Free Analyst Time
The rem sleep behavior disorder market is forecasted to grow by USD 438.6 million during 2023-2028, accelerating at a CAGR of 6.7% during the forecast period. The report on the rem sleep behavior disorder market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of neurological disorders, increasing geriatric population, and government support toward improving sleep behavior disorders.
The rem sleep behavior disorder market is segmented as below:
By End-user
- Hospitals
- Clinics
- Home healthcare
By Type
- Clonazepam
- Melatonin
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the rem sleep behavior disorder market covers the following areas:
- Rem Sleep Behavior Disorder Market sizing
- Rem Sleep Behavior Disorder Market forecast
- Rem Sleep Behavior Disorder Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by End-user
9 Market Segmentation by Type
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global rem sleep behavior disorder market: 21st Century HealthCare Inc, Aurobindo Pharma USA Inc., Bluebonnet Nutrition Corp., Cambrex Corp., Carlson Laboratories Inc., Church and Dwight Co. Inc., F. Hoffmann La Roche Ltd., GNC Holdings LLC, Jarrow Formulas Inc., Life Extension Foundation Buyers Club Inc., Lupin Ltd., Natrol LLC, NOW Health Group Inc., Pharmavite LLC, Solgar Inc., Sun Pharmaceutical Industries Ltd., Swanson Health Products Inc., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Zydus Lifesciences Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is integration of ai and ml into rem sleep behavior disorder detection."
According to the report, one of the major drivers for this market is the rising prevalence of neurological disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 21st Century HealthCare Inc
- Aurobindo Pharma USA Inc.
- Bluebonnet Nutrition Corp.
- Cambrex Corp.
- Carlson Laboratories Inc.
- Church and Dwight Co. Inc.
- F. Hoffmann La Roche Ltd.
- GNC Holdings LLC
- Jarrow Formulas Inc.
- Life Extension Foundation Buyers Club Inc.
- Lupin Ltd.
- Natrol LLC
- NOW Health Group Inc.
- Pharmavite LLC
- Solgar Inc.
- Sun Pharmaceutical Industries Ltd.
- Swanson Health Products Inc.
- Teva Pharmaceutical Industries Ltd.
- Torrent Pharmaceuticals Ltd.
- Zydus Lifesciences Ltd.
